NOVEMBER 22, 2019
Knight Therapeutics’ $142.8 Million Acquisition of 51,21% stake in Grupo Biotoscana.
GLOBAL LEGAL CHRONICLE
Davies Ward Phillips & Vineberg, Ferrere, Brigard Urrutia, Beccar Varela, Posadas, Posadas & Vecino, Estudio Garrido, Lobo de Rizzo and Bonn Steichen & Partners advised on the transaction…
Keywords: Mergers & Acquisitions
Knight Therapeutics’ $142.8 Million Acquisition of 51,21% stake in Grupo Biotoscana
See on Global Legal Chronicle website